MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
CERO CERo Therapeutics
- 0.056
- +0.002+3.89%
Close Dec 20 16:00 ET
- 0.056
- 0.000-0.71%
Post 19:59 ET
8.43MMarket Cap-0.02P/E (TTM)
0.060High0.051Low27.75MVolume0.055Open0.054Pre Close1.54MTurnover41.49%Turnover RatioLossP/E (Static)150.31MShares12.80052wk High-1.17P/B3.75MFloat Cap0.04752wk Low--Dividend TTM66.88MShs Float12.800Historical High--Div YieldTTM16.67%Amplitude0.047Historical Low0.055Avg Price1Lot Size
About CERo Therapeutics Company
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Company Profile
SymbolCERO
Company NameCERo Therapeutics
Listing DateNov 30, 2021
Founded2021
CEOMr. Chris Ehrlich
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address201 Haskins Way,Suite 230
CityOakland
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-215-731-9450
Websitehttp://www.cero.bio
Company Executives
- Name
- Position
- Salary
- Chris Ehrlich
- Interim Chairman of the Board and Chief Executive Officer
- --
- Andrew Albert Kucharchuk
- Chief Financial Officer
- --
- Dr. Kristen Pierce, PhD
- Chief Development Officer
- --
- Daniel Corey, M.D.
- Chief Technical Officer and Director
- 376.04K
- Kathleen D. Laporte
- Director
- --
- Shami J. Patel
- Director
- --
- Michael Byrnes
- Director
- --
- Brian G. Atwood
- Director
- --
- Dr. Lindsey Rolfe, M.D.
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.